Peace of Mind for People Living with Epilepsy
Embrace2 uses advanced machine learning to monitor seizure activity and is ideal for people with epilepsy or those at risk of having tonic-clonic seizures. This revolutionary device will alert carers when a seizure is taking place, and can automatically record a seizure diary through the Alert and Mate apps.
Want us to email you when it’s back in stock?
Join the waiting list
Pay later in 3 interest-free instalments of £83
Learn more about the Klarna payment option
Embrace2 is the latest epilepsy sensor from Empatica who have established themselves as leading experts in producing devices designed to detect seizures. Embrace2 is certified as a medical device in Europe and has gained FDA clearance in the US, which confirms the high rate of accuracy and reliability.
The wrist worn seizure monitor measures Electrodermal Activity (EDA), which means it detects changes in certain properties of the skin. This includes sweat secretion, a common indicator of potential seizure activity.
The Embrace2 sensor includes an accelerometer and gyroscope to monitor repetitive movement patterns and a temperature sensor, all of which assist with detecting potential tonic clonic seizures. The Embrace2 is the only epilepsy sensor available to combine both EDA and motion to detect seizures, which is proven to be more accurate than movement alone.
The Embrace2 is the only wrist-worn seizure monitor cleared by the FDA in the United States and certified as a medical device in Europe.
The Embrace2 sensor monitors changes in physiological conditions as well as movements that can be associated with seizures and communicates this data to a connected smartphone device.
When the Embrace2 detects signals that indicate seizure activity, it will use the connected smartphone to alert carers or loved ones via phone or SMS. The Embrace2 connects to the smartphone device via Bluetooth and must remain within 10m of the sensor.
Data and alerts are handled by two Embrace2 apps that can be downloaded via the App Store or Google Play.
The Embrace sensor is worn on the wrist and connects to a nearby smartphone or tablet via Bluetooth. Embrace2 weighs just 13g and is fully charged within 90 minutes. The battery lasts for 48 hours before it needs recharging.
Embrace2 is FDA cleared (US) and CE certified.
The Alert app collects real time data from the sensor and detects any unusual patterns in movement and the EDA. If potential seizure activity is detected, the app will use either the mobile data or WiFi to send an automated SMS message and call selected carers.The Alert features include:
This setting has extra sensitivity that helps the Embrace2 detect seizures during periods of rest, especially nocturnal seizures. Whether you are sleeping, reading a book or watching TV, Rest Mode will monitor your signals and immediately alert for possible tonic-clonic seizures.
Enhance alerts with your precise GPS location to expedite assistance. This is available in Standard and Plus subscription plans.
The Mate app has been designed to visualise the data retrieved from the Embrace2.
It provides really useful insights into your daily routine, giving users detailed statistics about their sleep and activity patterns and automatically logs detected seizures.
The Mate app is available for free on the App Store and Google Play.
To enjoy the benefits of the Embrace, the Alert app requires an annual subscription which you can set up once we deliver your device and you register it on the Empatica website. This is payable directly to Empatica. There are three options for you to choose from, available as an annual or monthly payment. If you select the annual option, you’ll get the equivalent of two months free.
| Lite | Standard | Plus | |
| £9.90per month | £19.90per month | £44.90per month | |
| £99per year | £199per year | £449per year | |
| Seizure Alerts | |||
| Carers | 1 | 3 | Unlimited |
| GPS Location | |||
| Rest Mode | |||
| Free 30 day trial of the Plus plan | N/A |
Embrace2 can be used by both adults and children. It is designed to detect tonic-clonic seizures lasting longer than 20 seconds.
Embrace2 has been designed to help detect signals associated with tonic clonic seizures. This includes movement and variations in the skin.
Embrace2 is not suitable to detect complex partial seizures, absence seizures or other non convulsive seizure.
When Embrace2 detects a tonic-clonic seizure, it communicates with its companion app
Alert on its paired mobile device to alert your caregivers with a phone call and text message.
Embrace2 does not predict seizures. It is designed to expedite assistance when a seizure occurs. To learn more about how Embrace2 works, watch our animated video .
The person using the Embrace2 will need two things:
1) A compatible smart device with a stable internet connection (via Wifi or mobile signal)
2) Alert App with an active subscription plan. This can be set up once we deliver the sensor by registering it on the Empatica website.
Remember, the person wearing Embrace2 needs the connected mobile device within a 10-metre radius at all times, but alerts can be sent to caregivers at any location.
iOS - Currently, the Embrace2 works on iOS 10 or higher. You can also use the iPod Touch (6th Gen) and all iPad models since 2013. Please note the Alert app is not optimised for the Pad screen.
Android – You can use the Embrace2 on devices running Android 5.0 (Lollipop) or higher, as long as they support Bluetooth Low Energy (BLE / 4.0 / Bluetooth Smart). We cannot guarantee full compatibility with devices using any custom or unofficial versions of Android.
Please be aware that not all Android devices that list Bluetooth 4.0 in their specifications support BLE. Please contact your device supplier to confirm your device meets this requirement.
The Alert App notifies your active caregivers with a phone call and text message containing your GPS location whenever Embrace2 detects a possible tonic-clonic seizure. Without Alert downloaded on your phone and configured with an active subscription plan, caregivers cannot be alerted.
The person using Embrace should download the Alert app on their paired mobile device. Caregivers won't need to download it to receive alerts.
The Mate App works with Alert to visualize Embrace data, enabling you to view your day at a glance. The Mate App will automatically collect reviewed seizure data from Alert and, together with the physical activity and rest data, provide you with an accurate, easy-to-view diary. You can bring Mate along with you to doctor visits or share your data via email.
Mate is for anyone who owns an Embrace2 and is actively using the Alert App with an active subscription plan.
Whilst you can use the Mate app without a subscription you do need one to get the maximum benefit of the Embrace2.
One of the main features of the Embrace2 is the alerts it sends to loved ones and carers. Without the Alert app and its subscription, this feature is not available. If you do not want to pay any subscription for an epilepsy sensor then you may want to look at our other wrist worn devices.
We can only sell the Embrace2 to residents within the UK. We're unable to distribute outside the UK. Please visit empatica.com for other regions.
We understand that not everyone can afford to buy an alarm in one go, so we’ve introduced an easier way to pay. Order your alarm today with Klarna, and you can spread the cost over 3 months, completely interest-free. Click here to learn more about Klarna.
If you or the person you are purchasing for has epilepsy or any long term medical condition you do not need to pay VAT for our products.
Please complete the VAT exemption section when you place your order. If you need to pay VAT or are unsure of your VAT status, please call 0800 180 8833.
